Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1972 3
1973 1
1975 2
1976 3
1977 8
1978 4
1979 6
1980 6
1981 7
1982 8
1983 15
1984 13
1985 30
1986 26
1987 20
1988 35
1989 38
1990 52
1991 40
1992 47
1993 73
1994 102
1995 85
1996 132
1997 154
1998 174
1999 174
2000 202
2001 192
2002 215
2003 231
2004 259
2005 311
2006 321
2007 339
2008 321
2009 381
2010 406
2011 479
2012 463
2013 512
2014 549
2015 544
2016 509
2017 537
2018 581
2019 540
2020 563
2021 587
2022 527
2023 517
2024 466
2025 537
2026 419

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,264 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation and management of febrile neutropenia in patients with cancer.
Cossey J, Cote MCB. Cossey J, et al. JAAPA. 2024 Aug 1;37(8):16-20. doi: 10.1097/01.JAA.0000000000000054. Epub 2024 Jul 25. JAAPA. 2024. PMID: 38980295 Review.
Febrile neutropenia is a common oncologic emergency that increases the risk for serious infection. This article reviews a joint American Society of Clinical Oncology and Infectious Diseases Society of America guideline for the evaluation and management of patients w …
Febrile neutropenia is a common oncologic emergency that increases the risk for serious infection. This article reviews a join …
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
Boccia R, Glaspy J, Crawford J, Aapro M. Boccia R, et al. Oncologist. 2022 Aug 5;27(8):625-636. doi: 10.1093/oncolo/oyac074. Oncologist. 2022. PMID: 35552754 Free PMC article. Review.
Neutropenia and febrile neutropenia (FN) are common complications of myelosuppressive chemotherapy. ...Neutropenia/FN also place a significant cost burden on US healthcare systems, with average costs per neutropenia/FN hospitalization estimated …
Neutropenia and febrile neutropenia (FN) are common complications of myelosuppressive chemotherapy. ...Neutropenia …
Febrile Neutropenia.
Patel K, West HJ. Patel K, et al. JAMA Oncol. 2017 Dec 1;3(12):1751. doi: 10.1001/jamaoncol.2017.1114. JAMA Oncol. 2017. PMID: 28750112 No abstract available.
Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies.
Stohs EJ, Abbas A, Freifeld A. Stohs EJ, et al. Transpl Infect Dis. 2024 Apr;26(2):e14236. doi: 10.1111/tid.14236. Epub 2024 Feb 13. Transpl Infect Dis. 2024. PMID: 38349035 Review.
Febrile neutropenia (FN) is common among hematologic malignancy patients, including recipients of hematopoietic cell transplantation (HCT) and cellular therapies such as chimeric antigen receptor (CAR)-T-cell therapy. ...
Febrile neutropenia (FN) is common among hematologic malignancy patients, including recipients of hematopoietic cell transplan …
[Management of febrile neutropenia].
Jannot X, Terrade JÉ, Méndez-Bailón M, Alonso-Ortiz MB, Andrès E, Lorenzo-Villalba N. Jannot X, et al. Rev Med Interne. 2025 Oct;46(10):580-587. doi: 10.1016/j.revmed.2025.04.005. Epub 2025 Apr 25. Rev Med Interne. 2025. PMID: 40280822 Free article. French.
Febrile neutropenia is a medical emergency requiring rapid and rigorous management considering the risk of severe infection. ...G-CSF should be used prophylactically, and is not an adjunct to antibiotic therapy for febrile neutropenia. Granulocyte tran …
Febrile neutropenia is a medical emergency requiring rapid and rigorous management considering the risk of severe infection. . …
Update on the management of febrile neutropenia in hematologic patients.
Escrihuela-Vidal F, Laporte J, Albasanz-Puig A, Gudiol C. Escrihuela-Vidal F, et al. Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):55-58. Rev Esp Quimioter. 2019. PMID: 31475812 Free PMC article. Review.
Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associated with high morbidity and mortality. ...
Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associat …
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
Lyman GH, Abella E, Pettengell R. Lyman GH, et al. Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9. doi: 10.1016/j.critrevonc.2013.12.006. Epub 2013 Dec 12. Crit Rev Oncol Hematol. 2014. PMID: 24434034
Neutropenia with fever (febrile neutropenia [FN]) is a serious consequence of myelosuppressive chemotherapy that usually results in hospitalization and the need for intravenous antibiotics. ...
Neutropenia with fever (febrile neutropenia [FN]) is a serious consequence of myelosuppressive chemotherapy that usuall …
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment.
Boşnak C, Akova M. Boşnak C, et al. Expert Rev Anti Infect Ther. 2025 Jun;23(6):327-341. doi: 10.1080/14787210.2025.2487149. Epub 2025 Apr 4. Expert Rev Anti Infect Ther. 2025. PMID: 40163819 Review.
INTRODUCTION: Although febrile neutropenia (FN) remains a major cause of morbidity and mortality in patients with hematologic malignancies and hematopoietic stem cell transplant (HSCT) recipients, the increasing prevalence of antimicrobial resistance necessitates a …
INTRODUCTION: Although febrile neutropenia (FN) remains a major cause of morbidity and mortality in patients with hematologic …
[Febrile neutropenia].
Takamatsu Y. Takamatsu Y. Rinsho Ketsueki. 2013 Oct;54(10):2014-22. Rinsho Ketsueki. 2013. PMID: 24064856 Review. Japanese. No abstract available.
Can febrile neutropenia re-invent its self?
Georgala A, Klastersky J. Georgala A, et al. Curr Opin Oncol. 2025 Mar 1;37(2):163-167. doi: 10.1097/CCO.0000000000001116. Epub 2025 Jan 15. Curr Opin Oncol. 2025. PMID: 39869037 Review.
PURPOSE OF REVIEW: Febrile neutropenia as a complication of cytotoxic chemotherapies, remains a major event in the medical journey of hematology and oncology patients. ...SUMMARY: In this setting, strategies that reduce the chances of febrile neutropenia …
PURPOSE OF REVIEW: Febrile neutropenia as a complication of cytotoxic chemotherapies, remains a major event in the medical jou …
11,264 results
You have reached the last available page of results. Please see the User Guide for more information.